Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Shares Outstanding (Weighted Average) (2018 - 2021)

Historic Shares Outstanding (Weighted Average) for Black Diamond Therapeutics (BDTX) over the last 4 years, with Q3 2021 value amounting to $36.2 million.

  • Black Diamond Therapeutics' Shares Outstanding (Weighted Average) rose 81.18% to $36.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $36.2 million, marking a year-over-year increase of 81.18%. This contributed to the annual value of $32.9 million for FY2020, which is 148530.9% up from last year.
  • As of Q3 2021, Black Diamond Therapeutics' Shares Outstanding (Weighted Average) stood at $36.2 million, which was up 81.18% from $36.2 million recorded in Q2 2021.
  • In the past 5 years, Black Diamond Therapeutics' Shares Outstanding (Weighted Average) registered a high of $36.2 million during Q3 2021, and its lowest value of $2.0 million during Q4 2018.
  • Moreover, its 4-year median value for Shares Outstanding (Weighted Average) was $28.3 million (2020), whereas its average is $20.6 million.
  • As far as peak fluctuations go, Black Diamond Therapeutics' Shares Outstanding (Weighted Average) surged by 164998.72% in 2020, and later soared by 75.69% in 2021.
  • Quarter analysis of 4 years shows Black Diamond Therapeutics' Shares Outstanding (Weighted Average) stood at $2.0 million in 2018, then rose by 2.83% to $2.1 million in 2019, then surged by 1485.31% to $32.9 million in 2020, then rose by 10.06% to $36.2 million in 2021.
  • Its last three reported values are $36.2 million in Q3 2021, $36.2 million for Q2 2021, and $36.1 million during Q1 2021.